title: Gluten-free diet induces regression of T-cell activation in the rectal mucosa of patients with celiac disease.
abstract: OBJECTIVE
  An increase in the number of intraepithelial lymphocytes (IEL) in the rectal epithelium of patients with active celiac disease has been described. No data are available about how they vary during a gluten-free diet. The aim of the study was to assess the effect of a gluten-free diet on T-cell activation in the rectal mucosa of adult patients with celiac disease.
  
  
  METHODS
  Frozen duodenal and rectal biopsies were available in four celiac patients (one male, three female, mean age 39 yr) both before and after 7 to 24 months on a gluten-free diet. Biopsy samples were stained using monoclonal antibodies directed against CD3, betaF1, TcRdelta1, CD25, and HLADR. Numbers of IEL were estimated by counting the peroxidase-stained cells per 100 epithelial cells. Four patients without histological abnormalities were used as control subjects.
  
  
  RESULTS
  In the four patients with active celiac disease but in none of the controls, CD25 was expressed by both duodenal and rectal lamina propria cells and HLADR was expressed by duodenal (4/4) and rectal (2/4) epithelial cells. In addition, two patients with active celiac disease had features of lymphocytic colitis, i.e., >20 IEL per 100 epithelial cells. After a gluten-free diet, the mean number of rectal CD3+ betaF1+ IEL decreased (9% vs 21%) and the expression of CD25 and HLADR was no longer present. These changes mirrored those found in the small intestinal biopsies.
  
  
  CONCLUSIONS
  These results suggest that in celiac disease, gluten-driven T-cell activation is not restricted to the proximal part of the intestine but is present on the whole intestinal length. Assessment of the effectiveness of a gluten-free diet through rectal biopsies warrants investigation, as it could lessen discomfort for patients and prove more cost-effective.
authors.affiliation: Service d'Hépato-gastroentérologie, Hôpital Laënnec Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Cellier
authors.forename: J P
authors.initials: JP
authors.lastname: Cervoni
authors.forename: N
authors.initials: N
authors.lastname: Patey
authors.forename: M
authors.initials: M
authors.lastname: Leborgne
authors.forename: P
authors.initials: P
authors.lastname: Marteau
authors.forename: B
authors.initials: B
authors.lastname: Landi
authors.forename: N
authors.initials: N
authors.lastname: Cerf-Bensussan
authors.forename: J P
authors.initials: JP
authors.lastname: Barbier
authors.forename: N
authors.initials: N
authors.lastname: Brousse
mesh_terms: D000328:Adult; D002446:Celiac Disease / Q000178:diet therapy / Q000276:immunology*; D018753:Diet, Protein-Restricted; D005260:Female; D005983:Glutens / Q000008:administration & dosage*; D006801:Humans; D018928:Immunity, Mucosal; D007413:Intestinal Mucosa / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012007:Rectum / Q000276:immunology*; D012189:Retrospective Studies; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D005983:Glutens